Clinical studies assessing immunogenicity and safety of intradermally administered influenza vaccines

Bibliography

• World Health Organization. Influenza fact sheet N°211. Available from: www who int/mediacentre/factsheets/fs211 [Last accessed July 5, 2010]
   Google Scholar
• Bhat N, Wright JG, Broder KR, Influenza-associated deaths among children in the United States, 2003-2004. N Engl J Med 2005;353(24):2559-67
   PubMed Web of Science ®Google Scholar
• Chiu SS, Lau YL, Chan KH, Influenza-related hospitalizations among children in Hong Kong. N Engl J Med 2002;347(26):2097-103
   PubMed Web of Science ®Google Scholar
• Izurieta HS, Thompson WW, Kramarz P, Influenza and the rates of hospitalization for respiratory disease among infants and young children. N Engl J Med 2000;342(4):232-9
   PubMed Web of Science ®Google Scholar
• Neuzil KM, Mellen BG, Wright PF, The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. N Engl J Med 2000;342(4):225-31
   PubMed Web of Science ®Google Scholar
• O'Brien MA, Uyeki TM, Shay DK, Incidence of outpatient visits and hospitalizations related to influenza in infants and young children. Pediatrics 2004;113(3 Pt 1):585-93
   PubMed Web of Science ®Google Scholar
• Poehling KA, Edwards KM, Weinberg GA, The underrecognized burden of influenza in young children. N Engl J Med 2006;355(1):31-40
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2006;55:1-42
   PubMedGoogle Scholar
• The European Agency for the Evaluation of Medicinal Products (EMA). Committee for proprietary medicinal products (CPMP). Note for guidance on harmonization of requirements for influenza vaccines. CPMP/BWP/214/96 1997
   Google Scholar
• Drummond M, Chevat C, Lothgren M. Do we fully understand the economic value of vaccines? Vaccine 2007;25(32):5945-57
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Prevention and control of seasonal influenza with vaccines. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2009;58:1-52
   PubMedGoogle Scholar
• World Health Organization. Prevention and control of influenza pandemics and annual epidemics. 56th World Assembly 2003; WHA56.19
   Google Scholar
• Council of the European Union. Council recommendation of 22 December 2009 on seasonal influenza vaccination. Available from: http://eur-lex europa eu/LexUriServ/LexUriServ do?uri = OJ:L:2009:348:0071:0072:EN:PDF 2009
   Google Scholar
• Blank PR, Schwenkglenks M, Szucs TD. Influenza vaccination coverage rates in five European countries during season 2006/07 and trends over six consecutive seasons. BMC Public Health 2008;8:272
   PubMed Web of Science ®Google Scholar
• de Lataillade C, Auvergne S, Delannoy I. 2005 and 2006 seasonal influenza vaccination coverage rates in 10 countries in Africa, Asia Pacific, Europe, Latin America and the Middle East. J Public Health Policy 2009;30(1):83-101
   PubMed Web of Science ®Google Scholar
• Tuft L. Active immunization against typhoid fever with particular reference to an intradermal method. J Lab Clin Med 1931;16:552
   Google Scholar
• Nicolas JF, Guy B. Intradermal, epidermal and transcutaneous vaccination: from immunology to clinical practice. Expert Rev Vaccines 2008;7(8):1201-14
   PubMed Web of Science ®Google Scholar
• Valladeau J, Saeland S. Cutaneous dendritic cells. Semin Immunol 2005;17(4):273-83
   PubMed Web of Science ®Google Scholar
• Le Borgne M, Etchart N, Goubier A, Dendritic cells rapidly recruited into epithelial tissues via CCR6/CCL20 are responsible for CD8+ T cell crosspriming in vivo. Immunity 2006;24(2):191-201
   PubMed Web of Science ®Google Scholar
• Allan RS, Waithman J, Bedoui S, Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL priming. Immunity 2006;25(1):153-62
   PubMed Web of Science ®Google Scholar
• Reddy ST, van d V, Simeoni E, Exploiting lymphatic transport and complement activation in nanoparticle vaccines. Nat Biotechnol 2007;25(10):1159-64
   PubMed Web of Science ®Google Scholar
• Briggs DJ, Banzhoff A, Nicolay U, Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine. Bull World Health Organ 2000;78(5):693-8
   PubMed Web of Science ®Google Scholar
• Bryan JP, Sjogren MH, Perine PL, Legters LJ. Low-dose intradermal and intramuscular vaccination against hepatitis B. Clin Infect Dis 1992;14(3):697-707
   PubMed Web of Science ®Google Scholar
• Redfield RR, Innis BL, Scott RM, Clinical evaluation of low-dose intradermally administered hepatitis B virus vaccine. A cost reduction strategy. JAMA 1985;254(22):3203-6
   PubMed Web of Science ®Google Scholar
• Payler DK, Skirrow MB. Letter: intradermal influenza vaccination. Br Med J 1974;2(5921):727
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. State-specific influenza vaccination coverage among adults aged > = 18 years–United States, 2003-2004 and 2005-2006 influenza seasons. MMWR Morb Mortal Wkly Rep 2007;56(37):953-9
   PubMedGoogle Scholar
• Belshe RB, Newman FK, Cannon J, Serum antibody responses after intradermal vaccination against influenza. N Engl J Med 2004;351(22):2286-94
   PubMed Web of Science ®Google Scholar
• Kenney RT, Frech SA, Muenz LR, Dose sparing with intradermal injection of influenza vaccine. N Engl J Med 2004;351(22):2295-301
   PubMed Web of Science ®Google Scholar
• World Health Organization. Current WHO phase of pandemic alert. Available from: http://www who int/csr/disease/avian_influenza/phase/en/ [Last accessed June 23, 2010]
   Google Scholar
• Valdespino-Gomez JL, Garcia-Garcia L, de Leon-Rosales SP. Vaccines against influenza A (H1N1) pandemic. Arch Med Res 2009;40(8):693-704
   PubMed Web of Science ®Google Scholar
• World Health Organization. Pandemic influenza vaccines: current status. Pandemic (H1N1) 2009 briefing note 11. Available from: www who int/csr/disease/swineflu/notes/pandemic_influenza_vaccines_20090924/en [Last accessed June 23, 2010]
   Google Scholar
• Partridge J, Kieny MP, the World Health Organization H1N1 influenza vaccine Taske Force. Global production of seasonal and pandemic (H1N1) influenza vaccines in 2009-2010 and comparison with previous estimates and global action plan targets. Vaccine 2010;28(30):4709-12
   Google Scholar
• Nava GM, ttene-Ramos MS, Ang JK, Escorcia M. Origins of the new influenza A(H1N1) virus: time to take action. Euro Surveill 2009;14(22)
   PubMedGoogle Scholar
• Goodwin K, Viboud C, Simonsen L. Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine 2006;24(8):1159-69
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2004;53:1-40
   PubMedGoogle Scholar
• Gomez CR, Nomellini V, Faunce DE, Kovacs EJ. Innate immunity and aging. Exp Gerontol 2008;43(8):718-28
   PubMed Web of Science ®Google Scholar
• Shurin MR, Shurin GV, Chatta GS. Aging and the dendritic cell system: implications for cancer. Crit Rev Oncol Hematol 2007;64(2):90-105
   PubMed Web of Science ®Google Scholar
• Paccalin M, Weinberger B, Nicolas J-F, The intradermal vaccination route–an attractive opportunity for influenza vaccination in elderly. Eur Geriatr Med 2010;1:82-7
   Google Scholar
• Potter CW, Oxford JS. Determinants of immunity to influenza infection in man. Br Med Bull 1979;35(1):69-75
   PubMed Web of Science ®Google Scholar
• Monto AS, Ohmit SE. Seasonal influenza vaccines: evolutions and future trends. Expert Rev Vaccines 2009;8(4):383-9
   PubMed Web of Science ®Google Scholar
• Van Gelder DW, Greenspan FS, Dufresne NE. Influenza vaccination; comparison of intracutaneous and subcutaneous methods. US Nav Med Bull 1947;47(1):197-206
   PubMedGoogle Scholar
• Weller TH, Cheever FS, Enders JF. Immunologic reactions following the intradermal inoculation of influenza A and B vaccine. Proc Soc Exp Biol Med 1948;67(1):96-101
   PubMed Web of Science ®Google Scholar
• Boger WP, Liu OC. Subcutaneous and intradermal vaccination with Asian influenza vaccine. J Am Med Assoc 1957;165(13):1687-9
   PubMed Web of Science ®Google Scholar
• Phillips CA, Forsyth BR, Christmas WA, Purified influenza vaccine: clinical and serologic responses to varying doses and different routes of immunization. J Infect Dis 1970;122(1):26-32
   PubMed Web of Science ®Google Scholar
• Marks MI, Eller JJ. Intradermal influenza immunization. Experience with Hong Kong vaccine. Am Rev Respir Dis 1971;103(4):579-81
   PubMed Web of Science ®Google Scholar
• McCarroll JR, Kilbourne ED. Immunization with Asian-strain influenza vaccine: equivalence of the subcutaneous and intradermal routes. N Engl J Med 1958;259(13):618-21
   PubMed Web of Science ®Google Scholar
• Foy HM, Sealey L, Cooney MK, Bor E. Efficacy of intradermally administered A2 Hong Kong vaccine. JAMA 1970;213(1):130
   PubMed Web of Science ®Google Scholar
• McElroy JT, Szwed JJ. Response to intradermal vaccination with A2, Hong Kong variant, influenza vaccine. N Engl J Med 1969;6:1076
   Google Scholar
• Brown H, Kasel JA, Freeman DM, The immunizing effect of influenza A/New Jersey/76 (Hsw1N1) virus vaccine administered intradermally and intramuscularly to adults. J Infect Dis 1977;136(Suppl):S466-71
   PubMedGoogle Scholar
• Halperin W, Weiss WI, Altman R, A comparison of the intradermal and subcutaneous routes of influenza vaccination with A/New Jersey/76 (swine flu) and A/Victoria/75: report of a study and review of the literature. Am J Public Health 1979;69(12):1247-51
   PubMed Web of Science ®Google Scholar
• Brooks JH, Criep LH, Ruben FL. Intradermal administration of bivalent and monovalent influenza vaccines. Ann Allergy 1977;39(2):110-12
   PubMedGoogle Scholar
• World Health Organization. Influenza vaccines. WHO position paper. Wkly Epidemiol Rec 2005;80:277-87
   PubMedGoogle Scholar
• Auewarakul P, Kositanont U, Sornsathapornkul P, Antibody responses after dose-sparing intradermal influenza vaccination. Vaccine 2007;25(4):659-63
   PubMed Web of Science ®Google Scholar
• Belshe RB, Newman FK, Wilkins K, Comparative immunogenicity of trivalent influenza vaccine administered by intradermal or intramuscular route in healthy adults. Vaccine 2007;25(37-38):6755-63
   PubMed Web of Science ®Google Scholar
• Kunzi V, Klap JM, Seiberling MK, Immunogenicity and safety of low dose virosomal adjuvanted influenza vaccine administered intradermally compared to intramuscular full dose administration. Vaccine 2009;27(27):3561-7
   PubMed Web of Science ®Google Scholar
• Kroon FP, van Dissel JT, de Jong JC, Antibody response after influenza vaccination in HIV-infected individuals: a consecutive 3-year study. Vaccine 2000;18(26):3040-9
   PubMed Web of Science ®Google Scholar
• Palache AM, Beyer WE, Luchters G, Influenza vaccines: the effect of vaccine dose on antibody response in primed populations during the ongoing interpandemic period. A review of the literature. Vaccine 1993;11(9):892-908
   PubMed Web of Science ®Google Scholar
• Herbert FA, Larke RP, Markstad EL. Comparison of responses to influenza A/New Jersey/76-A/Victoria/75 virus vaccine administered intradermally or subcutaneously to adults with chronic respiratory disease. J Infect Dis 1979;140(2):234-8
   PubMed Web of Science ®Google Scholar
• Chuaychoo B, Wongsurakiat P, Nana A, The immunogenicity of intradermal influenza vaccination in COPD patients. Vaccine 2010;28(24):4045-51
   PubMed Web of Science ®Google Scholar
• Khanlou H, Sanchez S, Babaie M, The safety and efficacy of dose-sparing intradermal administration of influenza vaccine in human immunodeficiency virus-positive patients. Arch Intern Med 2006;166(13):1417
   PubMed Web of Science ®Google Scholar
• Gelinck LB, van den Bemt BJ, Marijt WA, Intradermal influenza vaccination in immunocompromised patients is immunogenic and feasible. Vaccine 2009;27(18):2469-74
   PubMed Web of Science ®Google Scholar
• Manuel O, Humar A, Chen MH, Immunogenicity and safety of an intradermal boosting strategy for vaccination against influenza in lung transplant recipients. Am J Transplant 2007;7(11):2567-72
   PubMed Web of Science ®Google Scholar
• Jo YM, Song JY, Hwang IS, Dose sparing strategy with intradermal influenza vaccination in patients with solid cancer. J Med Virol 2009;81(4):722-7
   PubMed Web of Science ®Google Scholar
• Klein M, Huang N. The response of infants and children to Asian influenza vaccine administered by intradermal and subcutaneous routes. J Pediatr 1961;58:312-14
   Google Scholar
• Chiu SS, Peiris JS, Chan KH, Immunogenicity and safety of intradermal influenza immunization at a reduced dose in healthy children. Pediatrics 2007;119(6):1076-82
   PubMed Web of Science ®Google Scholar
• Sugimura T, Ito Y, Tananari Y, Improved antibody responses in infants less than 1 year old using intradermal influenza vaccination. Vaccine 2008;26(22):2700-5
   PubMed Web of Science ®Google Scholar
• Chiu SS, Chan KH, Tu W, Immunogenicity and safety of intradermal versus intramuscular route of influenza immunization in infants less than 6 months of age: a randomized controlled trial. Vaccine 2009;27(35):4834-9
   PubMed Web of Science ®Google Scholar
• Zaman K, Roy E, Arifeen SE, Effectiveness of maternal influenza immunization in mothers and infants. N Engl J Med 2008;359(15):1555-64
   PubMed Web of Science ®Google Scholar
• Lambert PH, Laurent PE. Intradermal vaccine delivery: will new delivery systems transform vaccine administration? Vaccine 2008;26(26):3197-208
   PubMed Web of Science ®Google Scholar
• Mikszta JA, Laurent PE. Cutaneous delivery of prophylactic and therapeutic vaccines: historical perspective and future outlook. Expert Rev Vaccines 2008;7(9):1329-39
   PubMed Web of Science ®Google Scholar
• Van Damme P, Oosterhuis-Kafeja F, Van der Wielen M, Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults. Vaccine 2009;27(3):454-9
   PubMed Web of Science ®Google Scholar
• Leroux-Roels I, Vets E, Freese R, Seasonal influenza vaccine delivered by intradermal microinjection: a randomised controlled safety and immunogenicity trial in adults. Vaccine 2008;26(51):6614-19
   PubMed Web of Science ®Google Scholar
• Beran J, Ambrozaitis A, Laiskonis A, Intradermal influenza vaccination of healthy adults using a new microinjection system: a 3-year randomised controlled safety and immunogenicity trial. BMC Med 2009;7:13
   PubMed Web of Science ®Google Scholar
• Holland D, Booy R, De LF, Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial. J Infect Dis 2008;198(5):650-8
   PubMed Web of Science ®Google Scholar
• Arnou R, Icardi G, De Decker M, Intradermal influenza vaccine for older adults: a randomized controlled multicenter phase III study. Vaccine 2009;27(52):7304-12
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Prevention and control of seasonal influenza with vaccines. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2007;56:1-54
   PubMedGoogle Scholar
• Mathei C, Van Damme P, Meheus A. Hepatitis B vaccine administration: comparison between jet-gun and syringe and needle. Vaccine 1997;15(4):402-4
   PubMed Web of Science ®Google Scholar
• Laurent PE, Bonnet S, Alchas P, Evaluation of the clinical performance of a new intradermal vaccine administration technique and associated delivery system. Vaccine 2007;25(52):8833-42
   PubMed Web of Science ®Google Scholar
• Mutsch M, Zhou W, Rhodes P, Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland. N Engl J Med 2004;350(9):896-903
   PubMed Web of Science ®Google Scholar
• Macroepidemiology of Influenza Vaccination (MIV) Study Group. The macro-epidemiology of influenza vaccination in 56 countries, 1997–2003. Vaccine 2005;23(44):5133-43
   PubMed Web of Science ®Google Scholar
• Chen D, Burger M, Chu Q, Epidermal powder immunization: cellular and molecular mechanisms for enhancing vaccine immunogenicity. Virus Res 2004;103(1-2):147-53
   PubMed Web of Science ®Google Scholar